R. Marsé-Fabregat

Atezolizumab Plus Bevacizumab as First-line Treatment for Patients With Metastatic Nonsquamous Non–Small Cell Lung Cancer With High Tumor Mutation Burden

B. Massuti, V. Calvo, M. Provencio, 2022, JAMA oncology.